Gene Expression Profiling of Paraffin-Embedded Primary Melanoma Using the DASL Assay Identifies Increased Osteopontin Expression as Predictive of Reduced Relapse-Free Survival

C. Conway, A. Mitra, R. Jewell, J. Randerson-Moor, S. Lobo, J. Nsengimana, S. Edward, D. S. Sanders, M. Cook, B. Powell, A. Boon, F. Elliott, F. de Kort, M. A. Knowles, D. T. Bishop, J. Newton-Bishop

    Research output: Contribution to journalArticle

    76 Citations (Scopus)
    LanguageEnglish
    Pages6939
    JournalClinical Cancer Research
    Volume15
    Issue number22
    DOIs
    Publication statusPublished - 2009

    Cite this

    Conway, C. ; Mitra, A. ; Jewell, R. ; Randerson-Moor, J. ; Lobo, S. ; Nsengimana, J. ; Edward, S. ; Sanders, D. S. ; Cook, M. ; Powell, B. ; Boon, A. ; Elliott, F. ; de Kort, F. ; Knowles, M. A. ; Bishop, D. T. ; Newton-Bishop, J. / Gene Expression Profiling of Paraffin-Embedded Primary Melanoma Using the DASL Assay Identifies Increased Osteopontin Expression as Predictive of Reduced Relapse-Free Survival. In: Clinical Cancer Research. 2009 ; Vol. 15, No. 22. pp. 6939.
    @article{963b6342ea684713a8466dba37e33255,
    title = "Gene Expression Profiling of Paraffin-Embedded Primary Melanoma Using the DASL Assay Identifies Increased Osteopontin Expression as Predictive of Reduced Relapse-Free Survival",
    author = "C. Conway and A. Mitra and R. Jewell and J. Randerson-Moor and S. Lobo and J. Nsengimana and S. Edward and Sanders, {D. S.} and M. Cook and B. Powell and A. Boon and F. Elliott and {de Kort}, F. and Knowles, {M. A.} and Bishop, {D. T.} and J. Newton-Bishop",
    year = "2009",
    doi = "10.1158/1078-0432.CCR-09-1631",
    language = "English",
    volume = "15",
    pages = "6939",
    journal = "Clinical Cancer Research",
    issn = "1078-0432",
    number = "22",

    }

    Conway, C, Mitra, A, Jewell, R, Randerson-Moor, J, Lobo, S, Nsengimana, J, Edward, S, Sanders, DS, Cook, M, Powell, B, Boon, A, Elliott, F, de Kort, F, Knowles, MA, Bishop, DT & Newton-Bishop, J 2009, 'Gene Expression Profiling of Paraffin-Embedded Primary Melanoma Using the DASL Assay Identifies Increased Osteopontin Expression as Predictive of Reduced Relapse-Free Survival', Clinical Cancer Research, vol. 15, no. 22, pp. 6939. https://doi.org/10.1158/1078-0432.CCR-09-1631

    Gene Expression Profiling of Paraffin-Embedded Primary Melanoma Using the DASL Assay Identifies Increased Osteopontin Expression as Predictive of Reduced Relapse-Free Survival. / Conway, C.; Mitra, A.; Jewell, R.; Randerson-Moor, J.; Lobo, S.; Nsengimana, J.; Edward, S.; Sanders, D. S.; Cook, M.; Powell, B.; Boon, A.; Elliott, F.; de Kort, F.; Knowles, M. A.; Bishop, D. T.; Newton-Bishop, J.

    In: Clinical Cancer Research, Vol. 15, No. 22, 2009, p. 6939.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Gene Expression Profiling of Paraffin-Embedded Primary Melanoma Using the DASL Assay Identifies Increased Osteopontin Expression as Predictive of Reduced Relapse-Free Survival

    AU - Conway, C.

    AU - Mitra, A.

    AU - Jewell, R.

    AU - Randerson-Moor, J.

    AU - Lobo, S.

    AU - Nsengimana, J.

    AU - Edward, S.

    AU - Sanders, D. S.

    AU - Cook, M.

    AU - Powell, B.

    AU - Boon, A.

    AU - Elliott, F.

    AU - de Kort, F.

    AU - Knowles, M. A.

    AU - Bishop, D. T.

    AU - Newton-Bishop, J.

    PY - 2009

    Y1 - 2009

    U2 - 10.1158/1078-0432.CCR-09-1631

    DO - 10.1158/1078-0432.CCR-09-1631

    M3 - Article

    VL - 15

    SP - 6939

    JO - Clinical Cancer Research

    T2 - Clinical Cancer Research

    JF - Clinical Cancer Research

    SN - 1078-0432

    IS - 22

    ER -